Zou Daoyuan, Lyu Fei, Pan Yiqi, Fan Xinyu, Du Jing, Mai Xiaoli
Department of Radiology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China.
Department of Ultrasound, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Quant Imaging Med Surg. 2025 Sep 1;15(9):7951-7963. doi: 10.21037/qims-2025-594. Epub 2025 Aug 11.
Accurate and timely diagnosis of thyroid cancer is critical for clinical care, and artificial intelligence can enhance this process. This study aims to develop and validate an intelligent assessment model called C-TNet, based on the Chinese Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules (C-TIRADS) and real-time elasticity imaging. The goal is to differentiate between benign and malignant characteristics of thyroid nodules classified as C-TIRADS category 4. We evaluated the performance of C-TNet against ultrasonographers and BMNet, a model trained exclusively on histopathological findings indicating benign or malignant nature.
The study included 3,545 patients with pathologically confirmed C-TIRADS category 4 thyroid nodules from two tertiary hospitals in China: Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine (n=3,463 patients) and Jiangyin People's Hospital (n=82 patients). The cohort from Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine was randomly divided into a training set and validation set (7:3 ratio), while the cohort from Jiangyin People's Hospital served as the external validation set. The C-TNet model was developed by extracting image features from the training set and integrating them with six commonly used classifier algorithms: logistic regression (LR), linear discriminant analysis (LDA), random forest (RF), kernel support vector machine (K-SVM), adaptive boosting (AdaBoost), and Naive Bayes (NB). Its performance was evaluated using both internal and external validation sets, with statistical differences analyzed through the Chi-squared test.
C-TNet model effectively integrates feature extraction from deep neural networks with a RF classifier, utilizing grayscale and elastography ultrasound data. It successfully differentiates benign from malignant thyroid nodules, achieving an area under the curve (AUC) of 0.873, comparable to the performance of senior physicians (AUC: 0.868).
The model demonstrates generalizability across diverse clinical settings, positioning itself as a transformative decision-support tool for enhancing the risk stratification of thyroid nodules.
甲状腺癌的准确及时诊断对临床治疗至关重要,人工智能可提升这一过程。本研究旨在基于中国甲状腺结节超声恶性风险分层指南(C-TIRADS)和实时弹性成像,开发并验证一种名为C-TNet的智能评估模型。目标是区分C-TIRADS 4类甲状腺结节的良恶性特征。我们将C-TNet的性能与超声检查医师以及BMNet(一种仅基于组织病理学结果显示良性或恶性性质进行训练的模型)进行了比较。
该研究纳入了来自中国两家三级医院的3545例经病理证实为C-TIRADS 4类甲状腺结节的患者:南京中医药大学附属中西医结合医院(3463例患者)和江阴市人民医院(82例患者)。南京中医药大学附属中西医结合医院的队列被随机分为训练集和验证集(7:3比例),而江阴市人民医院的队列作为外部验证集。C-TNet模型通过从训练集中提取图像特征,并将其与六种常用分类算法集成来开发:逻辑回归(LR)、线性判别分析(LDA)、随机森林(RF)、核支持向量机(K-SVM)、自适应增强(AdaBoost)和朴素贝叶斯(NB)。使用内部和外部验证集评估其性能,通过卡方检验分析统计差异。
C-TNet模型有效地将深度神经网络的特征提取与RF分类器相结合,利用了灰度和弹性成像超声数据。它成功地区分了甲状腺结节的良恶性,曲线下面积(AUC)达到0.873,与高级医师的表现相当(AUC:0.868)。
该模型在不同临床环境中具有通用性,是一种用于加强甲状腺结节风险分层的变革性决策支持工具。